Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.34 |
| ▸ | NAAA | Q02083 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.30 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.30 |
| ▸ | BLM | P54132 | 1/20 | 0.30 |
| ▸ | WRN | Q14191 | 1/20 | 0.30 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Butyric Acid SCHEMBL4605193 | 0.89 | FFAR3 (0.37) | NAAAMAPTKDM4EDUSP3MEN1 | |
| SCHEMBL27114713 | 0.87 | NAAA (0.40) | NAAAMAPTKDM4EDUSP3MEN1 | |
| SCHEMBL27114700 | 0.87 | NAAA (0.40) | NAAAMAPTKDM4EDUSP3MEN1 | |
| SCHEMBL428467 | 0.86 | MAPT (0.40) | MAPTKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL4603636 | 0.86 | MAPT (0.40) | MAPTKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL3729311 | 0.84 | MPI (0.33) | MPI | |
| Acetone SCHEMBL2803680 | 0.83 | MAPT (0.38) | MAPTKDM4EDUSP3MEN1KMT2A | |
| SCHEMBL7551882 | 0.83 | PRKCA (0.42) | MPIMAPT | |
| SCHEMBL3649429 | 0.83 | MGAM (0.36) | MPI | |
| SCHEMBL17767400 | 0.83 | PAX8 (0.36) | NAAAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114317659-B | Preparation method of soybean oligopeptide powder with multiple biological activities | 杭州佳嘉乐生物技术有限公司 | 2024-01-26 | — | — | CN | claimed |
| CN-115590240-A | Preparation method and product of heated cigarette for regulating nicotine slow-release effect | 广东中烟工业有限责任公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-114317659-A | Preparation method of soybean oligomeric active peptide powder with multiple biological activities | 杭州佳嘉乐生物技术有限公司 | 2022-04-12 | — | — | CN | claimed |
| US-20250163247-A1 | RESIN COMPOSITION, APPLICATION THEREOF, AND MOLDING METHOD THEREFOR | OSAKA GAS CHEMICALS CO., LTD. (JP) | 2025-05-22 | — | — | US | disclosed |
| CN-118647665-A | Resin composition, use thereof and molding method | 大阪燃气化学有限公司 | 2024-09-13 | — | — | CN | disclosed |
| CN-114317659-B | Preparation method of soybean oligopeptide powder with multiple biological activities | 杭州佳嘉乐生物技术有限公司 | 2024-01-26 | — | — | CN | disclosed |
| WO-2023166943-A1 | RESIN COMPOSITION, APPLICATION THEREOF, AND MOLDING METHOD THEREFOR | 大阪ガスケミカル株式会社 | 2023-09-07 | — | — | WO | disclosed |
| CN-115590240-A | Preparation method and product of heated cigarette for regulating nicotine slow-release effect | 广东中烟工业有限责任公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-114317659-A | Preparation method of soybean oligomeric active peptide powder with multiple biological activities | 杭州佳嘉乐生物技术有限公司 | 2022-04-12 | — | — | CN | disclosed |
| CN-112592379-B | beta-D-glucose short-chain fatty acid ester compound and preparation method and application thereof | 广东药科大学 | 2021-11-16 | — | — | CN | disclosed |
| CN-112592379-A | beta-D-glucose short-chain fatty acid ester compound and preparation method and application thereof | 广东药科大学 | 2021-04-02 | — | — | CN | disclosed |
| US-7276546-B2 | Carbohydrate esters and polyol esters as plasticizers for polymers, compositions and articles including such plasticizers and methods of using the same | EASTMAN CHEMICAL COMPANY (US) | 2007-10-02 | — | — | US | disclosed |
| WO-2007056125-A2 | CARBOXYALKYL CELLULOSE ESTERS FOR SUSTAINED DELIVERY OF PHARMACEUTICALLY ACTIVE SUBSTANCES | EASTMAN CHEMICAL COMPANY (US) | 2007-05-18 | — | — | WO | disclosed |
| WO-2007054972-A2 | METHOD OF PRODUCING SUCROSE-6-ACETATE BY WHOLE-CELL BIOCATALYSIS | PHARMED MEDICARE PVT. LTD. (IN) | 2007-05-18 | — | — | WO | disclosed |
| US-20070104787-A1 | Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances | EASTMAN CHEMICAL COMPANY | 2007-05-10 | — | — | US | disclosed |
| US-6977275-B2 | Carbohydrate esters and polyol esters as plasticizers for polymers, compositions and articles including such plasticizers and methods of using the same | EASTMAN CHEMICAL COMPANY (US) | 2005-12-20 | — | — | US | disclosed |
| US-20050228084-A1 | Novel carbohydrate esters and polyol esters as plasticizers for polymers, compositions and articles including such plasticizers and methods of using the same | BUCHANAN CHARLES M | 2005-10-13 | — | — | US | disclosed |
| EP-1465944-A1 | NOVEL CARBOHYDRATE ESTERS AND POLYOL ESTERS AS PLASTICIZERS FOR POLYMERS, COMPOSITIONS AND ARTICLES INCLUDING SUCH PLASTICIZERS AND METHODS OF USING THE SAME | EASTMAN CHEMICAL COMPANY (US) | 2004-10-13 | — | — | EP | disclosed |
| US-20030171458-A1 | Novel carbohydrate esters and polyol esters as plasticizers for polymers, compositions and articles including such plasticizers and methods of using the same | EASTMAN CHEMICAL COMPANY | 2003-09-11 | — | — | US | disclosed |
| WO-2003062314-A1 | NOVEL CARBOHYDRATE ESTERS AND POLYOL ESTERS AS PLASTICIZERS FOR POLYMERS, COMPOSITIONS AND ARTICLES INCLUDING SUCH PLASTICIZERS AND METHODS OF USING THE SAME | EASTMAN CHEMICAL COMPANY (US) | 2003-07-31 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070104787-A1 | Carboxyalkyl cellulose esters for sustained delivery of pharmaceutically active substances | SLC2A1, SLC2A8, SLC2A4 | MPI 811/4885NAAA 2892/4885MAPT 3571/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.